SCHEMBL19084240

SCHEMBL19084240

CC(=O)Oc1ccc2c(c1)-c1ccccc1-2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.56
MAPT P10636 4/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
LMNA P02545 3/20 0.53
ELANE P08246 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPK1 P28482 1/20 0.51
HSP90AA1 P07900 1/20 0.50
GAA P10253 1/20 0.50
NPC1 O15118 2/20 0.49
POLB P06746 1/20 0.49
ACHE P22303 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
USP2 O75604 1/20 0.48
HTT P42858 1/20 0.48
GLA P06280 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4642778 0.89 MAPT (0.61) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL15085173 0.87 MAPT (0.62) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL22336250 0.84 MAPT (0.55) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL6901954 0.82 PPARG (0.54) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL3786259 0.80 MAPT (0.49) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL3786320 0.80 LMNA (0.46) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL11213111 0.80 MAPT (0.55) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL4474802 0.79 CA12 (0.51) BACE1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL6260079 0.79 PTPRC (0.56) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL12821529 0.79 MAPT (0.58) BACE1MAPTALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190842-A1 O-HYDROXY-FUNCTIONALIZED DIAMINES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190842-A1 O-HYDROXY-FUNCTIONALIZED DIAMINES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE ALKBH3, AOC1, PAM BACE1 4840/4885MAPT 3676/4885ALDH1A1 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.